192 related articles for article (PubMed ID: 34862277)
21. Australian mental health care practitioners' practices and attitudes for encouraging smoking cessation and tobacco harm reduction in smokers with severe mental illness.
Sharma R; Meurk C; Bell S; Ford P; Gartner C
Int J Ment Health Nurs; 2018 Feb; 27(1):247-257. PubMed ID: 28160384
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial.
Bullen C; Verbiest M; Galea-Singer S; Kurdziel T; Laking G; Newcombe D; Parag V; Walker N
BMC Public Health; 2018 May; 18(1):596. PubMed ID: 29728074
[TBL] [Abstract][Full Text] [Related]
23. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
24. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness.
Japuntich SJ; Hammett PJ; Rogers ES; Fu S; Burgess DJ; El Shahawy O; Melzer AC; Noorbaloochi S; Krebs P; Sherman SE
Nicotine Tob Res; 2020 Aug; 22(9):1433-1438. PubMed ID: 31957794
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.
Anthenelli RM; Gaffney M; Benowitz NL; West R; McRae T; Russ C; Lawrence D; St Aubin L; Krishen A; Evins AE
J Gen Intern Med; 2019 Jun; 34(6):862-870. PubMed ID: 30847828
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Smoking Cessation Program Registration, Participation, Smoking Cessation Medication Utilization, and Abstinence Rates Between Smokers With and Without Schizophrenia, Schizo-affective Disorder, or Bipolar Disorder.
Kertes J; Stein Reisner O; Grunhaus L; Nezry R; Alcalay T; Azuri J; Neumark Y
Nicotine Tob Res; 2022 Mar; 24(5):670-678. PubMed ID: 34626108
[TBL] [Abstract][Full Text] [Related]
28. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
29. 'Real-world' effectiveness of smoking cessation treatments: a population study.
Kotz D; Brown J; West R
Addiction; 2014 Mar; 109(3):491-9. PubMed ID: 24372901
[TBL] [Abstract][Full Text] [Related]
30. Smoking cessation treatment for individuals with comorbid diabetes and serious mental illness in an integrated health care delivery system.
Hwong AR; Schmittdiel J; Schillinger D; Newcomer JW; Essock S; Zhu Z; Dyer W; Young-Wolff KC; Mangurian C
Addict Behav; 2021 Mar; 114():106697. PubMed ID: 33129613
[TBL] [Abstract][Full Text] [Related]
31. Attitudes about smoking cessation treatment, intention to quit, and cessation treatment utilization among young adult smokers with severe mental illnesses.
Brunette MF; Ferron JC; Aschbrenner KA; Pratt SI; Geiger P; Kosydar S
Addict Behav; 2019 Feb; 89():248-255. PubMed ID: 30343187
[TBL] [Abstract][Full Text] [Related]
32. The Impact of Smoking Cessation on Hospitalization and Psychiatric Medication Utilization among People with Serious Mental Illness.
Kertes J; Stein Reisner O; Grunhaus L; Neumark Y
Subst Use Misuse; 2021; 56(10):1543-1550. PubMed ID: 34193007
[No Abstract] [Full Text] [Related]
33. Nicotine receptor partial agonists for smoking cessation.
Livingstone-Banks J; Fanshawe TR; Thomas KH; Theodoulou A; Hajizadeh A; Hartman L; Lindson N
Cochrane Database Syst Rev; 2023 May; 5(5):CD006103. PubMed ID: 37142273
[TBL] [Abstract][Full Text] [Related]
34. General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study.
Johnson M; Anderson P; Lockhart I
BMC Fam Pract; 2014 Mar; 15():47. PubMed ID: 24645823
[TBL] [Abstract][Full Text] [Related]
35. Adaptation of a sustained care cessation intervention for smokers hospitalized for psychiatric disorders: Study protocol for a randomized controlled trial.
Hecht J; Rigotti NA; Minami H; Kjome KL; Bloom EL; Kahler CW; Price LH; Levy DE; Carpenter KM; Brown RA
Contemp Clin Trials; 2019 Aug; 83():18-26. PubMed ID: 31212100
[TBL] [Abstract][Full Text] [Related]
36. Nicotine replacement therapy sampling for smoking cessation within primary care: results from a pragmatic cluster randomized clinical trial.
Carpenter MJ; Wahlquist AE; Dahne J; Gray KM; Garrett-Mayer E; Cummings KM; Davis R; Egan BM
Addiction; 2020 Jul; 115(7):1358-1367. PubMed ID: 31916303
[TBL] [Abstract][Full Text] [Related]
37. Interventions to reduce tobacco use in people experiencing homelessness.
Vijayaraghavan M; Elser H; Frazer K; Lindson N; Apollonio D
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013413. PubMed ID: 33284989
[TBL] [Abstract][Full Text] [Related]
38. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
39. Smoking cessation in severe mental illness: what works?
Banham L; Gilbody S
Addiction; 2010 Jul; 105(7):1176-89. PubMed ID: 20491721
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
